Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 130 M113 M114 M135 M125 M175 M 549 M Research & development —————— — Operating income 509 M917 M693 M562 M120 M1.91 B 3.29 B Non-Operating Income, Total -98 M236 M80 M184 M-701 M414 M -23 M Interest expense, net of interest capitalized 127 M126 M125 M119 M118 M144 M 506 M Non-Operating Income, excl. Interest Expenses -225 M110 M-45 M65 M-819 M270 M -529 M Unusual income/expense —————— — Pretax income 646 M1.16 B912 M747 M166 M2.38 B 4.21 B Equity in earnings —————— — Taxes 137 M244 M219 M185 M46 M473 M 923 M Non-controlling/minority interest 15 M18 M6 M000 6 M After tax other income/expense —————— — Net income before discontinued operations 494 M899 M687 M562 M120 M1.91 B 3.28 B Discontinued operations —————— — Net income 494 M899 M687 M562 M120 M1.91 B 3.28 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 494 M899 M687 M562 M120 M1.91 B 3.28 B Basic earnings per share (Basic EPS) 0.771.421.090.90.192.04 4.22 Diluted earnings per share (Diluted EPS) 0.771.411.090.90.192.03 4.21 Average basic shares outstanding 643 M635 M628 M632 M616 M937 M — Diluted shares outstanding 645 M636 M629 M633 M618 M940 M — EBITDA 1.42 B1.83 B1.57 B1.45 B1.02 B3.33 B 7.38 B EBIT 509 M917 M693 M562 M120 M1.91 B 3.29 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 912 M914 M879 M890 M904 M1.42 B 4.09 B